On September 20^th 2022, Bioantibody has successfully obtained the ISO13485:2016 quality management system certificate issued by SGS, an internationally recognized testing, inspection and certification authority, after audit from each department. Prior to this, Bioantibody has obtained ISO13485:2016 quality management system certificate issued by Posi. Now we are recognized by two professional organizations.

The acquisition of ISO13485:2016 quality management system certificate is the recognition of our long-term efforts , and it is the driving force of our pursuit of excellence, to accelerate the achievement of the IVD industry benchmark.

For the future large-scale development of the company, Bioantibody will continue to keep customer demand-oriented and market-oriented, thoroughly implement ISO13485:2016 quality management system standards. Meanwhile, according to the actual operation of the company, Bioantibody will adhere to the continuous improvement, intensive IVD technology innovation and research to comprehensively improve the management level and service quality.

In this way, we could promote the sustainable and healthy growth of the company, so as to practice more mission and responsibility for the IVD development.